Skip to content

Mesenteric Vessel Sealing by Three Instruments

A Pilot Study to Compare Collateral Damage and Vessel Sealing Ability of LOTUS Ultrasonic Shears, Ethicon Harmonic Scalpel™ and LigaSure™ on Human Mesenteric Blood Vessels

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01121614
Enrollment
18
Registered
2010-05-12
Start date
2008-04-30
Completion date
2008-06-30
Last updated
2012-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Keywords

Harmonic scalpel, ultrasonic scalpel, LOTUS, LigaSure, vessel sealing, burst pressure, collateral damage

Brief summary

Ultrasonic cutting-coagulation devices (UCCD) are surgical instruments which use ultrasonic energy to cut through and coagulate tissue. An Ethicon version (trademarked Harmonic Scalpel and Ultracision) is used in a variety of surgical procedures. Its surgical performance has been directly compared with that of electrically powered diathermy instruments in animal and clinical trials. LOTUS is a company based in Ashburton, Devon, which has developed a UCCD that works in a slightly different way to the Harmonic Scalpel. There are also bipolar feedback diathermy instruments which use electrical energy to seal blood vessels, such as LigaSure. The aim of this project is to obtain data to design a fully powered trial to answer the research question: do LOTUS and Ethicon UCCDs and LigaSure bipolar device reliably seal and divide blood vessels? The investigators will also be examining the degree of collateral tissue damage caused by each instrument. Hypotheses * LOTUS UCCD, Ethicon Harmonic Scalpel and LigaSure are equivalent at sealing and dividing mesenteric blood vessels. * LOTUS UCCD, Ethicon Harmonic Scalpel and LigaSure cause equal amount of collateral damage when sealing and dividing blood vessels.

Interventions

DEVICELOTUS

Device used to seal blood vessel

DEVICEEthicon Harmonic Scalpel
DEVICELigaSure bipolar vessel sealing device

Sponsors

University Hospital Plymouth NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient undergoing laparoscopic or open colorectal resection

Exclusion criteria

* Pregnant or lactating women * Patients under eighteen years of age * History of coagulation abnormality * Inability to understand the nature of the study

Design outcomes

Primary

MeasureTime frameDescription
Bursting pressure of sealed vessel1 dayDesignated instrument is used to seal and divide a blood vessel which has been dissected from large bowel mesentery. The pressure at which the seal leaks is measured using a pressure transducer, this is known as the bursting pressure

Secondary

MeasureTime frameDescription
Success/failure to seal vessel1 dayInstrument is used to seal and divide a blood vessel, this outcome is to see whether the seal is complete
Depth of collateral damageAfter histological fixation is complete; within one weekEnergy-based surgical instruments cause a certain amount of thermal damage to the surrounding tissue, to compare the 3 instruments this depth of damage will be measured histologically

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026